tirzepatide vs metformin for pcos Can (dual GIP/GLP‑1 receptor agonist) be used off‑label to treat an overweight/obese woman with polycystic ovary syndrome and insulin resistance who has not responded to diet, exercise, and metformin, and what Metformin Vs Ozempic for Weight

Dual-hormone action studied for effects on satiety, appetite, and energy intake

Interested patients can complete a clinical intake form online, which assesses eligibility for GLP-1 therapy

I'm grateful for everything they've done to help me heal.Rachel McIntyreMay 29, 2025Truly exceptional team and care

This new study examines the heart health benefits of GLP-1RAs for people with both obesity and at least one autoimmune disease to determine if there is a reduction in serious cardiac events or other positive cardiovascular benefits

Regulatory Context The FDA issued a notice in 2023 removing BPC-157 from the list of bulk substances that may be compounded under section 503A and 503B of the Federal Food, Drug, and Cosmetic Act [2]